POET Technologies: A Photonics Pioneer Caught Between a Legal Storm and a Growth Narrative
Published on 07/24/2026 at 20:30 | Redaktion boerse-global.de
The numbers tell a stark story. POET Technologies shares have tumbled 8.35% in a single session to €6.15, extending a brutal 30-day slide that has wiped nearly 30% from the stock. The gap to the 52-week high of €18.84, touched in May, now stands at 67.36%. Yet for all the recent pain, the equity is still up 15.51% year-to-date — a contradiction that captures the deep divide between bulls and bears over this optically focused chip developer.
The Marvell Fallout That Shook the Foundation
The catalyst for the sell-off is unambiguous. In late April 2026, Marvell Semiconductor canceled all outstanding orders placed with Celestial AI, a subsidiary that POET had been supplying. Marvell cited a breach of confidentiality obligations, alleging that POET had improperly disclosed sensitive information about orders and deliveries. The move didn't just erase near-term revenue expectations — it shattered the linchpin of the bull case. The relationship with the Marvell/Celestial AI ecosystem was the cornerstone of POET's growth thesis, and its collapse has triggered a class-action lawsuit alleging securities fraud.
New supply agreements, including one with Lumilens, have done little to restore confidence. They demonstrate that POET's operations continue, but they don't address the fundamental issue: a major customer has publicly withdrawn its trust. That stain lingers.
The Dilution Dilemma
At a market capitalization of roughly €417.51 million, POET remains a company with minimal actual revenue — just $1.41 million from Asian markets, against a net loss of $81.65 million. To fund research and development, the company has repeatedly turned to equity financing, most recently closing a $250 million capital raise. Each round dilutes existing shareholders, a dynamic that analysts at Simply Wall St flag as a persistent risk.
Should investors sell immediately? Or is it worth buying POET Technologies?
The share count has ballooned over the years, capping upside potential even if the Optical-Interposer platform eventually gains traction. Scaling semiconductor manufacturing is capital-intensive, and that capital has to come from somewhere — typically at the expense of current holders.
Valuation: Cheap on Book, Expensive on Everything Else
The valuation debate is as muddled as the stock's trajectory. POET trades at a price-to-book ratio of 2.9, above the peer average of 1.1 but below the US semiconductor industry's 5.3. Of six common valuation metrics, the stock passes only one, according to Simply Wall St. That leaves it looking undervalued on a book-value basis but overpriced in a broader industry context.
Over three years, the stock has still gained 86.7%, and over twelve months it's up 21.8%. Those figures put the recent rout in perspective without explaining it. Analysts had been broadly bullish heading into spring, with a consensus price target of $7.30, supported by the Optical-Interposer technology's potential role in AI infrastructure. Whether those calls still hold is an open question, as no fresh commentary has emerged since the Marvell shock.
A Growing Market, a Shrinking Stock
The structural backdrop remains favorable. The silicon photonics components market for optical network terminals is projected to grow from $1.6 billion in 2025 to $2.01 billion this year, a 25.2% compound annual rate, and reach $4.88 billion by 2030. North America is the largest market, while Asia-Pacific — the region from which POET draws all its current revenue — is expanding fastest.
POET Technologies at a turning point? This analysis reveals what investors need to know now.
That tailwind, however, collides with a business that is losing money, a stock that has been extraordinarily volatile — annualized 30-day volatility stands at 91.32% — and a technical picture that offers no clear catalyst for a turnaround. The relative strength index sits at 39.3, approaching oversold territory but not yet flashing a buy signal.
Some investors see the current level as a bargain, noting the stock remains 95% above its 52-week low of €3.40. But until POET can demonstrate reliable revenue and win back the confidence of Tier-1 customers, the risks are likely to outweigh the rewards. The Marvell episode was a stark reminder of how quickly a single customer relationship can destabilize an entire valuation.
Ad
POET Technologies Stock: New Analysis - 24 July
Fresh POET Technologies information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
